Clinical Trial Update: RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer

View source ↗

Summary

A clinical trial is evaluating a RET inhibitor as neoadjuvant therapy for locally advanced RET-altered thyroid cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• RET inhibitor

Snippet

Sponsor: Fudan University | Conditions: Thyroid Cancer | Status: RECRUITING